Columnist Joe MacDonald describes his early adjustments to cope with the reality of his oldest son's hemophilia.

While packing for a move, the youngest son of columnist Cazandra Campos-MacDonald experiences a regular guest: joint pain.

Certain immune markers in the blood may help predict ITI response among hemophilia A patients given immune tolerance ...

Like many with hemophilia, columnist G Shellye Horowitz requires IV infusions of her medication — but the scars can raise some eyebrows.

Preventive treatment with Pfizer's Hympavzi can reduce bleeding rates in hemophilia A or B patients with inhibitors, new ...

Directly switching from Hemlibra to Mim8 was well tolerated in people with hemophilia A, with or without inhibitors, a study ...

A study reveals that the majority of Chinese patients with hemophilia A depend on on-demand therapy, resulting in limited ...

Columnist G Shellye Horowitz struggles to find care for her gastrointestinal issues due to the shortage of medical providers ...

The results of gene therapy for hemophilia B contrast with those of factor replacement therapies, where lifelong infusions ...

The condition is caused by a genetic mutation that leads to a deficiency or dysfunction of a protein called factor VIII (FVIII), which is crucial in the blood clotting process.. When someone has ...

Hemophilia type A, sometimes called classic hemophilia, is the most common. It’s caused by a deficiency in FVIII. Hemophilia type B, also known as Christmas Disease, is the second-most common type. It ...

Taking charge of your health when you have hemophilia is of great importance. Regardless of your hemophilia type — A, B or C — the goal is to keep your joints strong and healthy, and to keep extra ...